The plan, which will see New Jersey, US-headquartered Vyteris seek a buyer for its adhesive, patch-based technology platform, follows just months after it entered the contracting sector with the acquisition of CRO MediSync BioSrervices .
MediSync’s business plan, in addition to the provision of clinical trial, site and data management services, is to buy smaller CRO and site management organisations (SMOs) in the field of dermatology.
Evidently this is a strategy that Vyteris is very keen to take forward, given that it has already identified ‘multiple’ CRO takeover targets it plans to pursue over the next two years.
